Tripterygium glycosides and mesenchymal stem cells combination alleviated Sjögren's syndrome Features in mice and modulated the GRO-α/CXCR2 axis.

Zhang J, Li X, Wang Y, Hao J, Zhou Y

Open source

DOI
10.62347/hfyo1240
Published
2026
Container
American journal of translational research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.62347/hfyo1240,
  title = {Tripterygium glycosides and mesenchymal stem cells combination alleviated Sjögren's syndrome Features in mice and modulated the GRO-α/CXCR2 axis.},
  author = {Zhang J and Li X and Wang Y and Hao J and Zhou Y},
  year = {2026},
  journal = {American journal of translational research},
  doi = {10.62347/hfyo1240},
  url = {https://doi.org/10.62347/hfyo1240}
}

RIS

TY  - JOUR
TI  - Tripterygium glycosides and mesenchymal stem cells combination alleviated Sjögren's syndrome Features in mice and modulated the GRO-α/CXCR2 axis.
AU  - Zhang J
AU  - Li X
AU  - Wang Y
AU  - Hao J
AU  - Zhou Y
PY  - 2026
JO  - American journal of translational research
DO  - 10.62347/hfyo1240
UR  - https://doi.org/10.62347/hfyo1240
ER  - 

APA

J, Z., X, L., Y, W., J, H., & Y, Z. (2026). Tripterygium glycosides and mesenchymal stem cells combination alleviated Sjögren's syndrome Features in mice and modulated the GRO-α/CXCR2 axis.. American journal of translational research. https://doi.org/10.62347/hfyo1240

Source records